Preliminary results of the Dual Daily HIV and Syphilis Pre-Exposure Prophylaxis (DuDHS) Trial Tessa Lawson Tattersall

Tessa Lawson Tattersall, Joshua Edward, Saira Mohammed, Amit Gupta, Aidan Ablona, Mark Hull, Troy Grennan The incidence of syphilis is rising and is, along with HIV, overrepresented among men who have sex with men (MSM). Daily doxycycline has shown promising results as syphilis preexposure prophylaxis (PrEP); however, little is known about the feasibility of combined syphilis and HIV PrEP. The DuDHS trial is a randomized controlled trial to determine the feasibility of combined HIV and syphilis PrEP among MSM. Baseline demographics, sexual behaviours, incidence rates for sexually transmitted infection (STI), drug side effects, and adverse events in the first 24 weeks of follow-up are reported.

BC CDC Presenters

10/14/2020 9:15:00 PM